Registered Trials
-
jRCT2071210106
Phase 1/2/3Japan
Total Enrollment: 5,028
Official Trial Registration:
-
NCT04821674
Phase 1/2Japan
Total Enrollment: 152
Official Trial Registration:
Vaccine Type: RNA
This vaccine has reached Phase 3 trials.
This vaccine is not yet approved.
Japan
Total Enrollment: 5,028
Japan
Total Enrollment: 152
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.